Observation vs Upfront Surgery for Asymptomatic Kidney Stones in Children and Adults
Official title: Observational Approach Versus Surgical Intervention for Stones
Run by Children's Hospital of Philadelphia · NCT07718802 · Data updated 2026-11-12
This trial tests whether watching asymptomatic kidney stones or performing upfront surgery is better for reducing life disruption in patients aged 6 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years and up |
| Sex | All |
| Enrollment | 1658 (estimated) |
| Sponsor | Children's Hospital of Philadelphia Academic / other |
| Locations | 4 sites (Irvine, California and 3 other locations) |
| Status | Recruiting |
| Started | August 17, 2026 |
| Main results expected | May 31, 2031 |
| Study ends | October 1, 2032 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07718802 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 6 or older with asymptomatic, non-obstructive kidney stones measuring 4–10 mm.
✕Probably not a fit
Patients who have symptomatic stones, obstructive disease, or stones outside the 4–10 mm range may not benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Observational Approach versus Surgical Intervention for Asymptomatic Stone (OASIS) trial compares observation with upfront surgical treatment (URS or SWL) for asymptomatic, non-obstructive kidney stones 4–10 mm. It uses randomized assignment to either observation or surgery, with an optional non-randomized observational cohort for those who decline randomization. Outcomes focus on patient-centered measures and life disruption, alongside safety and healthcare utilization. The study is conducted across several U.S. centers with CHOP as lead sponsor and PCORI involvement, aiming to inform personalized management decisions.
Why it matters
Potential benefit: If successful, the trial could clarify which approach minimizes life disruption and helps tailor treatment to patient preferences.
How similar studies have gone: Previous work has explored management options for kidney stones, but robust randomized evidence specifically for asymptomatic stones guiding observation versus upfront surgery is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individuals age 6 or older 2. Diagnosis of kidney stone disease (nephrolithiasis) 3. Asymptomatic, non-obstructive kidney stones measuring 4 to 10 mm (inclusive) * Asymptomatic is defined as the absence of abdominal pain, flank pain, gross hematuria, and nausea and/or vomiting in the last 3 months that in the judgement of the site PI could be attributable to kidney stones. * Non-obstructive is defined as a stone in a renal calyx or stones in multiple renal calyces on CT, ultrasound, and/or x-ray obtained within 6 months of screening. 4. Informed consent and if appropriate, child assent. 5. Willingness to be randomized to surgery or observation Note: subjects otherwise eligible who decline randomization may be enrolled in a parallel observational cohort. 6. Fluent in English or Spanish 7. Willingness to be audio- and/or video- recorded during interviews Exclusion Criteria: 1. Untreated hydronephrosis or caliectasis 2. Pain (e.g., renal colic, abdominal pain) or gross hematuria attributed to kidney stones. 3. Recurrent symptomatic urinary tract infections (≥3 in 12 months or ≥2 in 6 months). A symptomatic urinary tract infection is defined as having at least one bladder or voiding symptom (e.g., frequency, urgency, dysuria) with bacteriuria (≥105 colony forming units/mL of no more than 2 urinary tract pathogens). 4. Stone in the renal pelvis, ureter, bladder or urethra 5. Pregnant females 6. Solitary kidney, transplant kidney, urinary diversion, medullary sponge kidney 7. Anatomic abnormality of the kidney (e.g., horseshoe kidney) 8. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures
Where it's running
-
University of California, Irvine
Irvine, California, United States Recruiting -
The Children's Hospital of Philadelphia
Hatboro, Pennsylvania, United States Recruiting -
University of Minnesota
Minneapolis, Minnesota, United States Not yet recruiting -
Columbia University Medical Center
New York, New York, United States Not yet recruiting
Study contacts
- Principal investigator: Gregory E Tasian, MD, MSc, MSCE — Children's Hospital of Philadelphia
- Study coordinator: Rebecca D McCune, BS, MS
- Email: mccuner@chop.edu
- Phone: 267-909-6030
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ho:YAG versus thulium fiber laser for mini-PCNL with the ClearPetra suction sheath
This trial will see if the Ho:YAG or thulium fiber laser clears kidney stones better during mini-PCNL with the ClearPetra suction sheath in adults with stones larger than 15 mm.
-
Empagliflozin and personalized diet for preventing calcium kidney stones
This study tests whether the diabetes drug empagliflozin plus tailored dietary counseling can reduce recurrent calcium kidney stones in adults.
-
LithoVue Elite ureteroscope with real‑time kidney pressure monitoring during flexible ureteroscopy.
This test will see if showing surgeons real‑time kidney pressure readings during flexible ureteroscopy changes how they operate and affects outcomes for adults having ureteroscopy for kidney or proximal ureter stones larger than 2 cm.
-
Investigating how the gut absorbs oxalate in kidney stone patients
This study is trying to see if people with kidney stones absorb more oxalate from their diet than healthy individuals, which might lead to more oxalate in their urine.
-
Using gut bacteria to reduce urinary oxalate in kidney stone patients
This study is testing if introducing a specific gut bacteria can help adults with calcium oxalate kidney stones lower the amount of oxalate in their urine.
-
Predicting kidney stone recurrence and complications using precision medicine
This study is trying to find out what causes kidney stones to come back so that we can help people avoid getting them again.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.